Hollie Franklin, Author at Drugs in Context

Use of safinamide for treatment of Parkinson disease: real-world data from Spain

María Isabel Morales Casado, Nuria López Ariztegui

Article Type

Review

Published

25 Jul 2025

This article collects and reviews reports from Spanish authors presented at national and international conferences on the use of safinamide in patients with Parkinson disease.

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations

Sarah L Anderson

Article Type

Review

Published

24 Jul 2025

This narrative review provides a comprehensive examination of the current landscape of GCGR-based combinations in phase III trials for the treatment of obesity.

Simulated client study on the dispensing practices for narcotic and psychotropic medications in community drug outlets in Ethiopia

Tirsit Ketsela Zeleke, Minichil Chanie Worku, Bantayehu Addis Tegegne, Fasil Bayafers Tamene, Gebremariam Wulie Geremew, Samuel Agegnew Wondm, Aschalew Mulatu Tefera, Ayelign Eshete Fitgu, Tekletsadik Tekleslassie Alemayehu, Muluken Adela Alemu, Rahel Belete Abebe, Kale Gubae, Abraham Teym

Article Type

Original Research

Published

16 Jul 2025

This study aimed to assess the extent and factors of non-prescription dispensing of narcotic and psychotropic medications at community drug retail outlets in Ethiopia.

Evaluating the efficacy of curcumin plus serratiopeptidase formulation in inflammatory acne: a quasi-experimental study

Shakila Junaid, Kiran Naz Khan, Farina Zameer, Muhammad Mudassir, Sadaf Bukhari, Neeta Maheshwary, Muhammad Athar Khan

Article Type

Original Research

Published

09 Jul 2025

This article evaluates the efficacy of a combined oral curcumin plus serratiopeptidase formulation as an adjunct to inflammatory acne therapy.

Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review

Amedeo Lucente, Andrea Taloni, Federico Fava, Giuseppe Giannaccare

Article Type

Case Report & Review

Published

26 Jun 2025

This article presents a case report on epiretinal membrane formation from the internal limiting membrane and examines the potential benefits of 0.5% indomethacin eye drops, supported by a brief literature review of related clinical studies.